MedPath
HSA Product

KAOMIX ORAL MIXTURE

Product approved by Health Sciences Authority (SG)

Basic Information

KAOMIX ORAL MIXTURE

SUSPENSION

Regulatory Information

SIN08787P

July 3, 1996

General Sale List

Therapeutic

ORAL

August 10, 2023

May 30, 2025

XA07BC30

Company Information

ICM PHARMA PTE. LTD.

ICM PHARMA PTE. LTD.

Active Ingredients

SODIUM BICARBONATE

Strength: 5% w/v

KAOLIN LIGHT

Strength: 20% w/v

© Copyright 2025. All Rights Reserved by MedPath